ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
John Hannah, 90, died March 14, 2022, in Sebastopol, California.
“Born in Ayrshire, Scotland, John moved to Cambridge, Massachusetts, after he earned a PhD to work under R. B. Woodward on the total synthesis of chlorophyll, and then moved to Cambridge, England, to work under Alexander Todd. At Merck & Co., he worked on anti-inflammatory agents and discovered the novel salicylic acid derivative diflunisal. John later discovered a new class of heterocyclylamino penicillins and cephalosporins antibiotics. Many may remember John from his oversight of the Merck & Co. Chemistry Department’s recruiting program at Harvard University and the Massachusetts Institute of Technology. After retirement, John moved to California where he enjoyed life in the Sonoma wine world.”—Alison Hannah, daughter
Most recent title: Senior investigator, Merck & Co.
Education: BSc, chemistry, University of Glasgow, 1953; PhD, chemistry, Imperial College London, 1956
Survivors: Son, Robert; daughter, Alison; five grandchildren
To recognize your late loved one or colleague, submit obituary information at cenm.ag/obits.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X